Cite

1. Enger SM, Ross RK, Henderson B, Bernstein L. Breast-feeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997;76:118-123.10.1038/bjc.1997.34622237989218743Search in Google Scholar

2. Rosa-Rosa JM, Pita G, Urioste M, Llort G, Brunet J, Lázaro C, Blanco I, Ramón Y, Cajal T, Díez O, de la Hoya M, Caldés T, Tejada MI, González-Neira A, Benítez J. Genome-wide linkage scan reveals three putative breast-cancer susceptibility loci. Am J Hum Genet 2009; 84:115-122.10.1016/j.ajhg.2008.12.013266800919147119Search in Google Scholar

3. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009;115:137-144.10.1007/s10549-008-0051-018481169Search in Google Scholar

4. Saadat M. Offspring sex ratio at birth and maternal breast cancer risk: A case-control study and meta-analysis of literature. EXCLI Journal 2010;9:76-81.Search in Google Scholar

5. Collaborative group on Hormonal Factors in Breast cancer. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer 2002; 87:1234-1245.10.1038/sj.bjc.6600596256250712439712Search in Google Scholar

6. Ueji M, Ueno E. Osei-Hirayama D, Saito T, Takahashi H, Kano K. Risk factors for breast cancer among Japanese women: a case-control study in Ibaraki, Japan. Breast Cancer 1998;5: 351-358.10.1007/BF0296743111091675Search in Google Scholar

7. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jap J Clil Oncol 2006;36:387-394.10.1093/jjco/hyl03116766567Search in Google Scholar

8. Zhang X, Condon JR, Rumbold AR, Cunningham J, Roder DM. Estimating cancer incidence in Indigenous Australians. Aust N Z J Public Health 2011;35:477-485.10.1111/j.1753-6405.2011.00762.x21973255Search in Google Scholar

9. Rollison DE, Brownson RC, Hathcock HL, Newschaffer CJ. Case-control study of tobacco smoke exposure and breast cancer risk in Delaware. BMC Cancer 2008;8:157.10.1186/1471-2407-8-157242406718518960Search in Google Scholar

10. Cotterchio M, Mirea L, Ozcelik H, Kreiger N. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and post-menopausal women in Ontario, Canada. Breast J 2014;20:468-480.10.1111/tbj.1230425052559Search in Google Scholar

11. Podkowa N, Komasińska P, Roszak M, Gryczka R, Grodecka-Gazdecka S, Łacka K. Health behaviours among women diagnosed with breast tumours. Pol Merkur Lekarski 2014;37:153-158.Search in Google Scholar

12. Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991; 49:526-530.10.1002/ijc.29104904091917153Search in Google Scholar

13. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 1994;139:1001–1007.10.1093/oxfordjournals.aje.a1169398178779Search in Google Scholar

14. Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, Malina J, Matson S. Survival of women with breast cancer in relation to smoking. Eur J Surgery 2000;166:852-858.10.1080/11024150044722711097150Search in Google Scholar

15. Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007;120:2672-2677.10.1002/ijc.2257517278091Search in Google Scholar

16. Mohamadynejad P, Saadat M. Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 2008;35:669-672.10.1007/s11033-007-9138-717874204Search in Google Scholar

17. Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 2010;37:155-158.10.1007/s11033-009-9565-819430957Search in Google Scholar

18. Teare MD, Wallance SA, Harris M, Howell A, Birch JM. Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer 1994;70:102-111.10.1038/bjc.1994.25720333238018518Search in Google Scholar

19. Osanai M, Lee GH. Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancer. Cancer Sci 2011;102:1158-1163.10.1111/j.1349-7006.2011.01920.x21371177Search in Google Scholar

20. Petrakis NL, Grurnke LD, Beelen TC, Castagnori N Jr, Craig JC. Nicotine in breast fluid of nonlactating women. Science 1978;199:303-305.10.1126/science.619458619458Search in Google Scholar

21. Li D, Wang M, Firozi PF, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH, DiGiovanni J. Characterization of a major aromatic DNA adduct detected in human breast tissue. Environ Mol Mutagen 2002;39: 193-200.10.1002/em.1006311921189Search in Google Scholar

22. Nakajima M, Kwon JT, Tanaka N. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther 2001;69:72-78.10.1067/mcp.2001.11268811180041Search in Google Scholar

23. Tyndale RF, Sellers EM. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther Drug Monit 2002;24:163-171.10.1097/00007691-200202000-0002611805739Search in Google Scholar

24. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;121:195-202.10.1007/s10549-009-0520-019760040Search in Google Scholar

25. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat 2010;121:703-708.10.1007/s10549-009-0636-219936916Search in Google Scholar

26. Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Dörk T, Schürmann P, Bogdanova N, Park-Simon TW, Couch FJ, Olson JE, Fasching PA, Beckmann MW, Häberle L, Ekici A, Hall P, Czene K, Liu J, Li J, Baisch C, Hamann U, Ko YD, Brauch H. CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2014;134:426-630.10.1002/ijc.28356388387623824676Search in Google Scholar

27. Tian Z, Li YL, Zhao L, Zhang CL. Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies. Gene 2013;524:168-174.10.1016/j.gene.2013.04.03823628800Search in Google Scholar

eISSN:
2335-075X
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other